Cargando…

Identifying Biomarkers of Subclinical Diabetes

Detalles Bibliográficos
Autor principal:	Kulkarni, Rohit N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402306/ https://www.ncbi.nlm.nih.gov/pubmed/22826312 http://dx.doi.org/10.2337/db12-0599

Ejemplares similares

Subclinical hypothyroidism in children: is it always subclinical?
por: Gallizzi, R., et al.
Publicado: (2018)

Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches
por: Sultana, Adiba, et al.
Publicado: (2022)

Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women
por: Harada, Paulo H. N., et al.
Publicado: (2017)

Screening for subclinical keratoconus
por: Arbelaez, Maria Clara, et al.
Publicado: (2013)

Analysis of the factors affecting the evolution over time of subclinical hypothyroidism in children
por: Valenzise, Mariella, et al.
Publicado: (2017)

Atrial Fibrillation: More Than a Subclinical Problem in Patients on Hemodialysis
por: Law, Mandy M., et al.
Publicado: (2021)

Biomarkers for Identifying Risk of Immune Reconstitution Inflammatory Syndrome
por: Wilkinson, Katalin Andrea, et al.
Publicado: (2016)

Separating signal from noise: the challenge of identifying useful biomarkers in sepsis
por: McCulloh, Russell J, et al.
Publicado: (2014)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Role of inflammatory biomarkers in diabetic peripheral neuropathy
por: Jin, Heung Yong, et al.
Publicado: (2018)

Symptomatic male with subclinical varicocele found on ultrasound evaluation
por: Majzoub, Ahmad, et al.
Publicado: (2016)

Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications
por: Blaha, Michael J., et al.
Publicado: (2022)

Emergence of a Predictive Clinical Biomarker for Diabetic Neuropathy
por: Kiernan, Matthew C.
Publicado: (2012)

A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
por: Legendre, Christophe
Publicado: (2019)

Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India
por: Misra, Neha, et al.
Publicado: (2020)

Commentary: Abnormal pupillary light reflexes - A sign of diabetic autonomic neuropathy
por: Saxena, Rohit, et al.
Publicado: (2019)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

A holistic approach to predicting diabetes risk via biomarkers
por: Cohen, Alan A.
Publicado: (2021)

Molecular Biomarkers of Oxygen Therapy in Patients with Diabetic Foot Ulcers
por: Oropallo, Alisha R., et al.
Publicado: (2021)

Targeting multimorbidity: Using healthspan and lifespan to identify biomarkers of ageing that pinpoint shared disease mechanisms
por: Deelen, Joris
Publicado: (2021)

Commentary: Strengthening the health system for providing care for diabetic retinopathy in South Asia
por: Misra, Neha, et al.
Publicado: (2020)

Asymptomatic postpubertal male with palpable left varicocele and subclinical right varicocele
por: Zhang, Yan
Publicado: (2016)

Subclinical myocardial dysfunction and dyssynchrony after Ross or Ross-Konno procedure
por: Ellenberger, Katherine, et al.
Publicado: (2020)

At the end of a two-year follow-up elevated TSH levels normalize or remain unchanged in most the children with subclinical hypothyroidism
por: De Luca, Filippo, et al.
Publicado: (2010)

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
por: Mauvais-Jarvis, Franck
Publicado: (2017)

Biomarkers in NHL
por: Malek, Sami N.
Publicado: (2011)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Advances in the study of subclinical AKI biomarkers
por: Zou, Chenchen, et al.
Publicado: (2022)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

Management Algorithm for Subclinical Hypoxemia in Coronavirus Disease-2019 Patients: Intercepting the “Silent Killer”
por: Galwankar, Sagar C., et al.
Publicado: (2020)

“Prediction Is Very Hard, Especially About the Future”: New Biomarkers for Type 2 Diabetes?
por: Lowe, William L., et al.
Publicado: (2013)

Biomarkers for early diagnosis of diabetic kidney disease: still a long way to go
por: Kumar, Vivek, et al.
Publicado: (2022)

Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines
por: Toro-Salazar, Olga H., et al.
Publicado: (2018)

Functional MRI Signal Fluctuations: A Preclinical Biomarker for Cognitive Impairment in Type 2 Diabetes?
por: Belfort-DeAguiar, Renata, et al.
Publicado: (2014)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Commentary on “Clinical outcome of pediatric and young adult subclinical varicoceles: a single-institution experience”
por: Palmisano, Franco, et al.
Publicado: (2021)

Subclinical myocardial dysfunction and reduced left ventricular global longitudinal strain in patients with COVID-19
por: Lee, Wei-Chieh
Publicado: (2021)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Tenascin-C: an emerging prognostic biomarker in diabetes
por: Yonebayashi, Saori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_efi2cmsobrontd0k5ndhpcle5h